無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

医師が処方する薬用化粧品の世界市場

Physician Dispensed Cosmeceuticals

発行 Global Industry Analysts, Inc. 商品コード 248900
出版日 ページ情報 英文 180 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.52円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
医師が処方する薬用化粧品の世界市場 Physician Dispensed Cosmeceuticals
出版日: 2018年05月01日 ページ情報: 英文 180 Pages
概要

当レポートでは、世界の医師の調剤による薬用化粧品市場について調査し、市場の動向と2016〜2024年の予測、地域別動向、および市場に参入する主要企業のプロファイルなどをまとめています。

第1章 イントロダクション、調査方法、製品定義

第2章 エグゼクティブサマリー

  • 業界概要
    • 医師の調剤による薬用化粧品:医療とビューティの提供
    • アジア太平洋地域が将来の大きな成長
    • スキンケア製品
    • 競合環境
  • 成長促進因子と市場動向
    • 人生中盤の危機
    • 薬用化粧品の消費者
    • 保険未加入患者向けにカスタマイズしたソリューション
    • 侵襲性手技への潜在的経路
    • 顧客ベースを広げるメーカー
    • アンチエージング製品
    • 幹細胞技術 他
  • 市場障壁概要
    • 医師の調剤による薬用化粧品をめぐる議論
    • 倫理的見解
    • 製品の有効性
    • Medispaの登場
    • 患者の任意と要件
    • 適切な製品を決定する上での課題
  • 販売シナリオ
    • 販売を強化する電子商取引
    • ソーシャルネットワーキング
  • 美容市場:概要
  • 製品概要
  • 近年の業界活動
  • 世界の主要企業
    • Allergan Plc
    • SkinMedica, Inc.
    • Athena Cosmetics, Inc.
    • Biopelle, Inc.
    • Clinique Laboratories, LLC
    • iS CLINICAL (
    • Jan Marini Skin Research, Inc.
    • La Roche-Posay Laboratoire Pharmaceutique
    • Neutrogena Corp.
    • Obagi Medical Products, Inc.
    • Pacific Bioscience Laboratories, Inc.
    • SkinCeuticals
    • Solta Medical, Inc.
    • Stiefel Laboratories, Inc.
    • ZO® Skin Health, Inc.
  • 世界市場見通し

第3章 市場

  • 米国
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • その他の諸国
目次
Product Code: MCP-7466

This report analyzes the worldwide markets for Physician Dispensed Cosmeceuticals in US$ Thousand. The Global and the US markets are further analyzed by the following Segments: Physician Dispensed Skin Care Products, and Physician Dispensed Eyelash Products. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 68 companies including many key and niche players such as -

Allergan Plc
Athena Cosmetics, Inc.
Biopelle, Inc.
Clinique Laboratories, LLC
iS CLINICAL
Jan Marini Skin Research, Inc.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Physician Dispensed Cosmeceuticals: Delivering Health and Beauty
  • Asia-Pacific to Witness Strong Growth in the Future
  • Physician Dispensed Skin Care Products Gain Traction
  • Competitive Landscape
    • Table 1: Leading Brands in the Global Physician-Dispensed Topicals Market (2016): Percentage Breakdown of Value Sales for Jan Marini Skincare, La-Roche Posay, Latisse, Obagi, Revitalash, SkinCeuticals, SkinMedica, Teoxane, ZO Skin Health and Others (includes corresponding Graph/Chart)

2. GROWTH DRIVERS AND MARKET TRENDS

  • Mid-Life Crisis - A Key Growth Driver
  • Cosmeceutical Consumers: A Highly Informed, Aesthetically-Conscious Group
  • Natural Ingredients Gain Attention
  • What's Next in Ingredients?
  • Women Account for Highest Spends on Skin Care
  • Customized Solutions for Uninsured Patients to go a Long Way
  • Physician Dispensed Cosmeceuticals - A Potential Path to Invasive Procedures
  • Post Procedure Topical Products in Demand
  • Physician Dispensing Outsmarts Conventional Retail Brands
  • Manufacturers Widen Customer Base
  • Innovative Ingredients Gain Focus
  • Anti-Aging Products: The Largest Segment in Skin Care Cosmeceuticals
  • Major Anti-Aging Ingredients of Cosmeceuticals
  • Stem Cell Technology: The New Frontier
  • Skin Brightening and Lightening Products - A High Growth Market
  • Companies Focus on Complementary Products
  • Possible Ban on Hydroquinone Stimulates Search for Other Pigment Control Products

3. AN INSIGHT INTO MARKET BARRIERS

  • Debate Surrounding Physician Dispensing of Cosmeceuticals
  • Ethical Perspective
  • Product Efficacy
  • Emergence of Medispas
  • Patient Discretion and Requirement
  • Challenges in Determining the Right Product

4. DISTRIBUTION SCENARIO

  • E-Commerce to Reinforce Sales of Physician Dispensed Products
  • Social Networking - A New Marketing Tool

5. AESTHETICS MARKET: A BRIEF INSIGHT

  • A Prelude
    • Table 2: World Aesthetics Market (2016): Percentage Breakdown of Revenues by Segment (includes corresponding Graph/Chart)
  • Historical and Recent Past Perspective
  • Aging Population: A Weighty Demographic Driver
    • Table 3: Global Aging Population in Select Regions/Countries: Population of 60+ Individuals in '000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)
  • Societal Pressure to Look Young Peps Demand for Facial Aesthetics
  • Undesirable Side Effects: A Challenge to Reckon With

6. PRODUCT OVERVIEW

7. RECENT INDUSTRY ACTIVITY

  • Croma-Pharma and Universkin Enter into Exclusive Licensing and Distribution Agreement
  • Revision Skincare(r) Introduces Nectifirm(r) ADVANCED
  • ALASTIN Skincare(tm) Launches ALASTIN HydraTint ProMineral Broad Spectrum Sunscreen SPF 36
  • Mercellar Introduces Exuviance in Kenya
  • CALECIM(r) Professional Introduces Restorative Hydration Cream
  • SkinMedica to Market Histogen's CCM Products
  • Sientra Takes Over U.S. Rights to bioCorneum(r) Advanced Silicone Gel Scar Management Therapy
  • Valeant to Divest Obagi Medical Products Business
  • Actavis Takes Over Allergan Inc., Changes Name to Allergan Plc.
  • MDRejuvena Unveils New Skin Care Product Line

8. FOCUS ON SELECT GLOBAL PLAYERS

  • Allergan Plc (Ireland)
  • SkinMedica, Inc. (USA)
  • Athena Cosmetics, Inc. (USA)
  • Biopelle, Inc. (USA)
  • Clinique Laboratories, LLC (USA)
  • iS CLINICAL (USA)
  • Jan Marini Skin Research, Inc. (USA)
  • La Roche-Posay Laboratoire Pharmaceutique (France)
  • Neutrogena Corp. (USA)
  • Obagi Medical Products, Inc. (USA)
  • Pacific Bioscience Laboratories, Inc. (USA)
  • SkinCeuticals (USA)
  • Solta Medical, Inc. (USA)
  • Stiefel Laboratories, Inc. (USA)
  • ZO(r) Skin Health, Inc. (USA)

9. GLOBAL MARKET PERSPECTIVE

    • Table 4: World Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 5: World Historic Review for Physician Dispensed Cosmeceuticals by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 6: World 14-Year Perspective for Physician Dispensed Cosmeceuticals by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2011, 2017 and 2024 (includes corresponding Graph/Chart)
    • Table 7: World Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals by Segment - Eyelash Products and Skin Care Products Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 8: World Historic Review for Physician Dispensed Cosmeceuticals by Segment - Eyelash Products and Skin Care Products Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 9: World 14-Year Perspective for Physician Dispensed Cosmeceuticals by Segment - Percentage Breakdown of Value Sales for Eyelash Products and Skin Care Products Markets for Years 2011, 2017 and 2024 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • The Largest Physician Dispensed Cosmeceuticals Market Globally
    • Anti-aging Cosmeceuticals and Sunscreens to Drive Growth
    • Baby-boomers and Working Females Propel Demand for Skin Care Products
    • Table 10: US Population Breakdown by Age Group for 2015 (includes corresponding Graph/Chart)
    • Competition
    • Hydroquinone-free Products Attract Attention
    • Strategic Corporate Developments
    • Select Players
  • B. Market Analytics
    • Table 11: US Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 12: US Historic Review for Physician Dispensed Cosmeceuticals by Product Segment - Eyelash Products and Skin Care Products Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 13: US 14-Year Perspective for Physician Dispensed Cosmeceuticals by Product Segment - Percentage Breakdown of Value Sales for Eyelash Products and Skin Care Products Markets for Years 2011, 2017 and 2024 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Outlook
    • Anti-Aging Cosmeceuticals Market - A Review
  • B. Market Analytics
    • Table 14: Canadian Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 15: Canadian Historic Review for Physician Dispensed Cosmeceuticals Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Measuring the Potential of Anti-Ageing Cosmeceuticals
  • B. Market Analytics
    • Table 16: Japanese Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 17: Japanese Historic Review for Physician Dispensed Cosmeceuticals Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Outlook
    • Skin Care Market in Europe
    • Strategic Corporate Development
    • Select Players
  • B. Market Analytics
    • Table 18: European Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 19: European Historic Review for Physician Dispensed Cosmeceuticals Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Asian Aesthetics Market - A Promising Sector
  • B. Market Analytics
    • Table 20: Asia-Pacific Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 21: Asia-Pacific Historic Review for Physician Dispensed Cosmeceuticals by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 22: Asia-Pacific 14-Year Perspective for Physician Dispensed Cosmeceuticals by Geographic Region - Percentage Breakdown of Value Sales for China, India and Rest of Asia-Pacific Markets for Years 2011, 2017 and 2024 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • Elderly Population Spurs Growth
    • Women - The Major Consumer Group for Anti-Aging Products
  • B. Market Analytics
    • Table 23: Chinese Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 24: Chinese Historic Review for Physician Dispensed Cosmeceuticals Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

5b. INDIA

  • A. Market Analysis
    • Bright Outlook for Anti-Aging Cosmeceuticals Prescribed by Dermatologists
    • FMCG Companies Maintain their Lead in Cosmeceuticals Segment in India
  • B. Market Analytics
    • Table 25: Indian Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 26: Indian Historic Review for Physician Dispensed Cosmeceuticals Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 27: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 28: Rest of Asia-Pacific Historic Review for Physician Dispensed Cosmeceuticals Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • A. Market Analysis
    • Anti-Aging Products in Latin America: A Promising Space
  • B. Market Analytics
    • Table 29: Latin American Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals by Geographic Region - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 30: Latin American Historic Review for Physician Dispensed Cosmeceuticals by Geographic Region - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)
    • Table 31: Latin American 14-Year Perspective for Physician Dispensed Cosmeceuticals by Geographic Region - Percentage Breakdown of Value Sales for Brazil, Mexico and Rest of Latin America Markets for Years 2011, 2017 and 2024 (includes corresponding Graph/Chart)

6a. BRAZIL

  • A. Market Analysis
    • Anti-aging Products: A Significant Market
  • B. Market Analytics
    • Table 32: Brazilian Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 33: Brazilian Historic Review for Physician Dispensed Cosmeceuticals Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

6b. MEXICO

  • A. Market Analysis
    • Anti-aging Products to Witness Steady Growth
  • B. Market Analytics
    • Table 34: Mexican Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 35: Mexican Historic Review for Physician Dispensed Cosmeceuticals Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

6c. REST OF LATIN AMERICA

  • Market Analysis
    • Table 36: Rest of Latin America Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 37: Rest of Latin America Historic Review for Physician Dispensed Cosmeceuticals Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Outlook
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 38: Rest of World Recent Past, Current and Future Analysis for Physician Dispensed Cosmeceuticals Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)
    • Table 39: Rest of World Historic Review for Physician Dispensed Cosmeceuticals Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

  • Total Companies Profiled: 68 (including Divisions/Subsidiaries - 76) The United States (57) Canada (5) Europe (11) - France (5) - Germany (2) - The United Kingdom (1) - Rest of Europe (3) Asia-Pacific (Excluding Japan) (2) Africa (1) PHYSICIAN DISPENSED COSMECEUTICALS MCP-7466 CONTENTS
Back to Top